Alzheimer's Disease Blood Testing in Clinical Practice: How to Order, Interpret, and Act on Results

This case-driven session translates Alzheimer’s disease (AD) blood test evidence into clinical action. 

Using three representative vignettes (Positive, Indeterminate, Negative), a neurologist, primary care physician, and laboratory director will guide participants through ordering pathways, result interpretation and patient communication. Faculty will also address key biological and demographic confounders (e.g., comorbidities, co-pathology) as well as important pre-analytical factors that may impact result interpretation and patient care decisions. The session will outline a practical, stepwise framework for clinical implementation and provide example language for use in the clinic.

OBJECTIVES:

• Integrate AD blood tests with a team approach across neurology, primary care and the laboratory.
• Select the most appropriate ordering pathway based on patient presentation and access.
• Recognize pre-analytical and clinical factors that may influence result interpretation.
• Formulate clear, empathetic communications with patients and caregivers, incorporating shared decision-making around confirmatory testing and therapy discussions.

ACCREDIATIONS:

• Continuing education credit: One P.A.C.E.® credit-hour will be provided for this complimentary basic level program. Fujirebio is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.
• This program is approved for 1 Florida Laboratory CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563
• Certificate of Attendance is available for all attendees.